Article -> Article Details

Market Overview

The France animal health market was valued at USD 1,247.68 Million in 2024 and is projected to reach USD 1,785.65 Million by 2033. The market is expected to grow at a CAGR of 3.65% during the forecast period 2025-2033. Growth is driven by technological advancements, increasing demand for animal protein, and stringent animal welfare regulations in France. 

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

France Animal Health Market Key Takeaways

• Current Market Size: USD 1,247.68 Million (2024)
• CAGR: 3.65% (2025-2033)
• Forecast Period: 2025-2033
• Technological innovations are enhancing animal health services in France, facilitating better monitoring and treatment.
• Increasing demand for animal protein is driving livestock producers to invest more in animal health products such as vaccines and supplements.
• Strict animal welfare laws in France, including bans on certain antibiotics in animal feed, are encouraging development of alternative therapies.
• Government subsidies and incentives support animal health and disease prevention programs, fostering industry growth.
• Companies like Ceva Animal Health have expanded their presence, enhancing the technological capability of the market.

Sample Request Link: https://www.imarcgroup.com/france-animal-health-market/requestsample

Market Growth Factors

The increasing global demand for animal protein is another major driver of the animal health market in France. The rise in population and per capita protein consumption increases the demand for efficient animal husbandry to produce maximum animal protein with limited resources. French farmers are investing in animal health products such as vaccines, supplements, and other products that help combat disease and maximize productivity per kilogram at a lower cost. As increased animal welfare and regenerative production systems are demanded by French society, farmers are investing in more sustainable animal-health products to avoid outbreaks. In 2024, the average French consumed 31.6 kilograms of poultry (chiefly chicken) and 31 kilograms of pork and charcuterie, attesting to their high levels of protein consumption.

Tight regulations and animal welfare standards in France are affecting the animal health market by lending to a higher demand for veterinary medicines and services. For example, some antibiotics have been banned from animal feed, alternative therapies such as probiotics and vaccines have been promoted, and the industry has received subsidies and other incentives to invest in disease prevention. Its recommendations support the development of veterinary e-health companies and reinforce the French leadership in the field of animal welfare and health.

Animal health in France is being supported by technology with the use of digital technologies, wearable monitors, genetic testing, and artificial intelligence (AI)-based diagnostic tools. These can be used to identify the early stages of a disease and improve animal welfare. Improved efficiency and reduced antibiotic usage can be achieved using a range of technologies. The use of improved therapeutics and vaccines, and livestock bred for disease resistance, may also aid control. The 2024-built world headquarters of Ceva Animal Health in Libourne is a recent example of this trend.

Market Segmentation

• Animal Type
• Commercial: The segment includes animals reared for commercial purposes, focusing on livestock productivity and health management.
• Companion: This segment covers pets and companion animals receiving health services and products for wellbeing and disease prevention.
• Product Type
• Pharmaceuticals: Includes veterinary medicines and drugs used to treat and prevent animal diseases.
• Biologicals: Products such as vaccines and diagnostically active agents derived from living organisms.
• Medicinal Feed Additives: Additives incorporated in animal feed for health benefits including growth promotion and disease resistance.
• Diagnostics: Tools and technologies used for diagnosing animal health status and diseases.

Regional Insights

The report covers major regions including Paris Region, Auvergne-Rhône-Alpes, Nouvelle-Aquitaine, Hauts-de-France, Occitanie, Provence Alpes Côte d’Azur, Grand Est, and others. Specific market shares or CAGR by region are not provided in the source. The comprehensive regional analysis supports a thorough understanding of market dynamics across France.

Recent Developments & News

In 2024, Ceva Animal Health, the fifth-largest global animal health firm, officially opened its new global headquarters in Libourne, France. This facility serves as an international platform reflecting the company’s sustainability goals and business commitment. The event signals significant expansion and technological advancement within the France animal health market.

Key Players

• Ceva Animal Health

Customization Note

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302